A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus

NCT04493541 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Cutaneous

Interventions

DRUG: BMS-986256
OTHER: BMS-986256 Placebo

Sponsor

Bristol-Myers Squibb